Filing Details

Accession Number:
0001382963-20-000032
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-03-13 18:26:51
Reporting Period:
2020-03-04
Accepted Time:
2020-03-13 18:26:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1460702 Ritter Pharmaceuticals Inc RTTR Pharmaceutical Preparations (2834) 263474527
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1631674 E. Ira Ritter Ritter Pharmaceuticals, Inc.
1880 Century Park East, Suite 1000
Los Angeles CA 90067
Cob, Cso Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-03-04 18,750 $0.38 81,727 No 4 S Indirect By Stonehenge Partners LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Stonehenge Partners LLC
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 625 Indirect By Trust
Footnotes
  1. As a managing partner of Stonehenge Partners LLC, the Reporting Person may be deemed the beneficial owner of these shares. The Reporting Person expressly disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein.
  2. These shares are held in a retirement plan trust of which the Reporting Person and his spouse are trustees. The Reporting Person's spouse and the revocable trust of the Reporting Person and his spouse are beneficiaries of the retirement plan trust. The Reporting Person expressly disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.